Skip to main content

NFXL1 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-29356

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-29356

Key Product Details

Species Reactivity

Human

Applications

Immunoprecipitation

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

between 100 and 150

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Applications for NFXL1 Antibody

Application
Recommended Usage

Immunoprecipitation

Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

Tris-citrate/phosphate buffer, pH 7 to 8

Preservative

0.09% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C. Do not freeze.

Background: NFXL1

NFXL1 (Nuclear Transcription Factor, X-Box Binding-Like 1) is thought to have a role in signaling molecules. NFXL1 is known to have interactions with SARM1 and UBC. NFXL1 has been studied in relation to colon cancer and malaria.

Alternate Names

FLJ16294, HOZFP, NF-X1-type zinc finger protein NFXL1, nuclear transcription factor, X-box binding-like 1, Ovarian zinc finger protein, OZFP, up-regulated in colon cancer 5, URCC5

Gene Symbol

NFXL1

Additional NFXL1 Products

Product Documents for NFXL1 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for NFXL1 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...